Funds raised: $230 million series B round, $100 million series A round
Employees: 55 currently. Plans call for 100 employees by year’s end.
Investors: Hillhouse Capital, Invus, The Baupost Group, Polaris Partners, ARCH Venture Partners and Omega Funds
Headquarters: San Diego
Year founded: 2015
Company description: Gossamer is developing drugs for a swath of disease areas, covering autoimmune, allergy/inflammation, immuno-oncology and fibrosis.
San Diego By going big, Gossamer Bio looks to break the mold...